Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

FDA grants fast track designation to Insys' sublingual naloxone for opioid overdose

Oct. 30, 2015

U.S. and Italian team reports development of FAAH inhibitors

Oct. 29, 2015

NIAID awards SRI International contract to develop treatments for radiation exposure

Oct. 16, 2015

Addex Therapeutics reports efficacy of ADX-71441 in models of alcohol use disorder

Oct. 14, 2015

Pluristem and FDA agree development pathway for PLX-R18 in ARS

Sep. 21, 2015

Department of Defense awards Cleveland BioLabs contract for development of entolimod

Sep. 7, 2015

Probuphine NDA resubmitted to FDA

Sep. 1, 2015

Regenerative peptide mitigates radiation-induced gastrointestinal damage

Aug. 24, 2015

FDA approves IND for Saniona's NS-2359 in the treatment of cocaine addiction

Aug. 17, 2015

Virginia Commonwealth University patents NO-releasing allosteric Hb modifiers

July 21, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...